• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Words of wisdom. Re: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

作者信息

Bill-Axelson Anna, Bratt Ola

机构信息

Department of Urology, Institution of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.

出版信息

Eur Urol. 2015 Jan;67(1):175. doi: 10.1016/j.eururo.2014.09.048. Epub 2014 Nov 25.

DOI:10.1016/j.eururo.2014.09.048
PMID:25528396
Abstract
摘要

相似文献

1
Words of wisdom. Re: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Eur Urol. 2015 Jan;67(1):175. doi: 10.1016/j.eururo.2014.09.048. Epub 2014 Nov 25.
2
Words of wisdom. Re: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.至理名言。关于：前列腺癌筛查与死亡率：欧洲前列腺癌筛查随机研究（ERSPC）13年随访结果。
Eur Urol. 2014 Dec;66(6):1187-8. doi: 10.1016/j.eururo.2014.08.044.
3
Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up.关于：前列腺癌筛查与死亡率：欧洲前列腺癌筛查随机研究（ERSPC）13年随访结果
J Urol. 2015 Aug;194(2):392. doi: 10.1016/j.juro.2015.05.064. Epub 2015 May 18.
4
Screening for prostate cancer (PC)--an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC).前列腺癌筛查——欧洲前列腺癌筛查随机研究（ERSPC）近期研究结果的更新
Urol Oncol. 2008 Sep-Oct;26(5):533-41. doi: 10.1016/j.urolonc.2008.03.011.
5
[Mortality due to prostate cancer in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Results after a 15-year follow-up].[欧洲前列腺癌筛查随机研究（ERSPC）西班牙分部中前列腺癌导致的死亡率。15年随访结果]
Actas Urol Esp. 2012 Jul-Aug;36(7):403-9. doi: 10.1016/j.acuro.2011.10.013. Epub 2012 Jan 24.
6
Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).欧洲前列腺癌筛查随机研究（ERSPC）中分期变化与死亡率差异之间的相关性。
BJU Int. 2016 Nov;118(5):677-680. doi: 10.1111/bju.13505. Epub 2016 May 20.
7
Appraising the European randomized study of screening for prostate cancer: what do the results mean?评估欧洲前列腺癌筛查随机研究：结果意味着什么？
Asian J Androl. 2015 Mar-Apr;17(2):221-2. doi: 10.4103/1008-682X.142131.
8
Prostate cancer screening: and yet it moves!前列腺癌筛查：然而它仍在发展！
Asian J Androl. 2015 May-Jun;17(3):437-8. doi: 10.4103/1008-682X.143310.
9
[Early detection of prostate cancer--recommendations after 13 years of follow-up in the European randomised study].[前列腺癌的早期检测——欧洲随机研究13年随访后的建议]
Ned Tijdschr Geneeskd. 2015;159:A8677.
10
Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trial.欧洲随机前列腺癌筛查试验（ERSPC）中按中心划分的设计校正后死亡率降低的变异情况。
J Med Screen. 2017 Jun;24(2):98-103. doi: 10.1177/0969141316652174. Epub 2016 Aug 9.

引用本文的文献

1
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.纳米颗粒作为实验和临床应用中的诊疗载体——聚焦前列腺癌和乳腺癌
Int J Mol Sci. 2017 May 20;18(5):1102. doi: 10.3390/ijms18051102.
2
What's new in screening in 2015?2015年筛查领域有哪些新进展？
Curr Opin Urol. 2016 Sep;26(5):447-58. doi: 10.1097/MOU.0000000000000321.